TABLE 2.
Participant characteristics
Participant | Age | Gender | Days post onset | Lesion | Aphasia | BDAE Severity Rating (0-5) | |
---|---|---|---|---|---|---|---|
Allocated to Usual Care SLT | |||||||
GRERO | 73 | M | 68 | Traumatic brain injury with left temporal intracranial hemorrhage | Moderate-severe Wernicke's | 2 | |
LEBPI | 70 | M | 14 | Left middle cerebral artery infarct | Mild-moderate anomic | 2 | |
FOXSU | 63 | F | 19 | Left middle cerebral artery infarct and intraventricular hemorrhage | Moderate undifferentiated fluent | 2 | |
TATMI | 45 | M | 41 | Left basal ganglia hemorrhage | Moderate-severe Broca's, moderate apraxia | 2 | |
MILSU (discontinued) | 47 | F | 10 | Left middle cerebral artery infarct (administered tPA**) | Moderate conduction | 2 | |
GILRI (discontinued) | 66 | M | 23 | Left parietal infarct | Mild-moderate conduction | 4 | |
MARRI (discontinued) | 53 | M | 7 | Left middle cerebral artery infarct (administered tPA**) | Mild-moderate anomic→ resolved | 3 | |
Allocated to Usual Care SLT + CILT | Paired with | ||||||
KISNO | 45 | M | 21 | Left middle cerebral artery infarct with parietal bleed | Moderate conduction | 3 | SIMLA |
SIMLA | 60 | M | 49 | Traumatic brain injury with left subdural/subarachnoid hemorrhages | Moderate-severe undifferentiated fluent | 2 | KISNO |
MCCLA | 37 | F | 11 | Left middle cerebral artery infarct | Moderate-severe Broca's, moderate apraxia | 2 | SALMA |
SALMA | 76 | F | 17 | Left middle cerebral artery infarct | Severe Broca's, reduced comprehension, apraxia | 1 | MCCLA |
SAPJO | 53 | M | 25 | Left middle cerebral artery infarct | Severe Broca's, reduced comprehension, apraxia | 1 | BARWI→volunteer* |
BARWI (Discontinued) | 55 | M | 36 | Left temporoparietal intracranial hemorrhage | Severe Broca's, reduced comprehension, apraxia | 1 | SAPJO |
BDAE = Boston Diagnostic Aphasia Examination. SLT = Speech and Language Therapy. CILT = Constraint Induced Language Therapy
SAPJO was originally paired with BARWI who was discontinued secondary to the severity of his apraxia. A trained volunteer served as SAPJO's partner for remaining CILT sessions.
tPA = Tissue plasminogen activator, administered during acute hospitalization (prior to admission to inpatient rehabilitation)